Finally published PBA-0405 data!
Frontiers | A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies
IntroductionB-cell malignancies, including chronic lymphocytic leukemia (CLL), pose a significant clinical challenge due to high relapse rates and dose-limit…
Niina Veitonmäki
Excited to share that the co-laboration article has just been published.
Huge thanks to everyone who contributed to this, and helping to bring this article to life!